MannKind - Afrezza Scripts Remain Flat As Company Hires New Executive

|
About: MannKind Corporation (MNKD)
by: Spencer Osborne
This article is exclusive for subscribers.
Spencer Osborne
Growth, value, special situations, momentum
Summary

MannKind hire David Kendall as Chief Medical Officer.

Afrezza scripts come in flat.

Cash estimate at about $37 million.

Earlier this week, MannKind (MNKD) announced that David Kendall would be joining the company as its Chief Medical Officer. Kendall is expected to head up MannKind's scientific research, clinical development, regulatory, and medical